BioStock: Cline Scientific ready for the next challenge

During the summer, biotech company Cline Scientific successfully carried out a share issue to raise approximately SEK 6.1 million before expenses. With the new capital, the company can take on the next challenge – to drive the stem cell project StemCART towards clinical studies. BioStock talked to CEO Hanne Evenbratt about the Cline's path forward.

Read the interview with Cline Scientific's CEO Hanne Evenbratt at biostock.se:

https://www.biostock.se/en/2023/09/cline-scientific-ready-for-the-next-challenge/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en